322 related articles for article (PubMed ID: 34064969)
21. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
[No Abstract] [Full Text] [Related]
22. Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma.
Fan CS; Chen LL; Hsu TA; Chen CC; Chua KV; Li CP; Huang TS
J Hematol Oncol; 2019 Dec; 12(1):138. PubMed ID: 31847880
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
Wang S; Huang S; Sun YL
Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
[TBL] [Abstract][Full Text] [Related]
24. MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.
Hu J; Li L; Chen H; Zhang G; Liu H; Kong R; Chen H; Wang Y; Li Y; Tian F; Lv X; Li G; Sun B
Cell Death Dis; 2018 Jul; 9(8):807. PubMed ID: 30042387
[TBL] [Abstract][Full Text] [Related]
25. Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma.
Mittal K; Ogden A; Reid MD; Rida PC; Varambally S; Aneja R
Cell Cycle; 2015; 14(17):2798-809. PubMed ID: 26151406
[TBL] [Abstract][Full Text] [Related]
26. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
[TBL] [Abstract][Full Text] [Related]
27. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
Carbone C; Piro G; Fassan M; Tamburrino A; Mina MM; Zanotto M; Chiao PJ; Bassi C; Scarpa A; Tortora G; Melisi D
Oncotarget; 2015 May; 6(15):13822-34. PubMed ID: 25360865
[TBL] [Abstract][Full Text] [Related]
28. Nicotine promotes tumor progression and epithelial-mesenchymal transition by regulating the miR-155-5p/NDFIP1 axis in pancreatic ductal adenocarcinoma.
Ben Q; Sun Y; Liu J; Wang W; Zou D; Yuan Y
Pancreatology; 2020 Jun; 20(4):698-708. PubMed ID: 32354626
[TBL] [Abstract][Full Text] [Related]
29. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer.
Ji Q; Li H; Cai Z; Yuan X; Pu X; Huang Y; Fu S; Chu L; Jiang C; Xue J; Zhang X; Li R
Int J Biol Sci; 2023; 19(6):1894-1909. PubMed ID: 37063425
[TBL] [Abstract][Full Text] [Related]
30. Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma.
Guinn S; Kinny-Köster B; Tandurella JA; Mitchell JT; Sidiropoulos DN; Loth M; Lyman MR; Pucsek AB; Zabransky DJ; Lee JW; Kartalia E; Ramani M; Seppälä TT; Cherry C; Suri R; Zlomke H; Patel J; He J; Wolfgang CL; Yu J; Zheng L; Ryan DP; Ting DT; Kimmelman A; Gupta A; Danilova L; Elisseeff JH; Wood LD; Stein-O'Brien G; Kagohara LT; Jaffee EM; Burkhart RA; Fertig EJ; Zimmerman JW
Cancer Res; 2024 May; 84(9):1517-1533. PubMed ID: 38587552
[TBL] [Abstract][Full Text] [Related]
31. ADAMTS12 promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer.
He RZ; Zheng JH; Yao HF; Xu DP; Yang MW; Liu DJ; Sun YW; Huo YM
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):169-178. PubMed ID: 35508435
[TBL] [Abstract][Full Text] [Related]
32. Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer.
Bulle A; Lim KH
Signal Transduct Target Ther; 2020 Oct; 5(1):249. PubMed ID: 33122631
[TBL] [Abstract][Full Text] [Related]
33. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
[TBL] [Abstract][Full Text] [Related]
34. Interaction between pancreatic cancer cells and tumor-associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migration of macrophages.
Meng F; Li C; Li W; Gao Z; Guo K; Song S
IUBMB Life; 2014 Dec; 66(12):835-46. PubMed ID: 25557640
[TBL] [Abstract][Full Text] [Related]
35. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications.
Yang J; Ren B; Ren J; Yang G; Fang Y; Wang X; Zhou F; You L; Zhao Y
J Exp Clin Cancer Res; 2023 Jun; 42(1):155. PubMed ID: 37370109
[TBL] [Abstract][Full Text] [Related]
37. Role of histone deacetylase 1 in distant metastasis of pancreatic ductal cancer.
Shinke G; Yamada D; Eguchi H; Iwagami Y; Asaoka T; Noda T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
Cancer Sci; 2018 Aug; 109(8):2520-2531. PubMed ID: 29917299
[TBL] [Abstract][Full Text] [Related]
38. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
39. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.
Stark AP; Chang HH; Jung X; Moro A; Hertzer K; Xu M; Schmidt A; Hines OJ; Eibl G
Surgery; 2015 Dec; 158(6):1564-72. PubMed ID: 26297056
[TBL] [Abstract][Full Text] [Related]
40. Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer.
Liu Z; Hayashi H; Matsumura K; Ogata Y; Sato H; Shiraishi Y; Uemura N; Miyata T; Higashi T; Nakagawa S; Mima K; Imai K; Baba H
Br J Cancer; 2023 Mar; 128(5):844-856. PubMed ID: 36536047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]